Austria & Germany Call For ‘Competitiveness Check’ On EU Pharma Revision Package
Executive Summary
The two countries want the European Commission’s proposals to be more closely examined for their possible negative effect on pharmaceutical investment decisions. The industry federation EFPIA says it is surprised more EU member states aren’t taking the same stance.